VRS
Virginia Retirement Systems Portfolio holdings
AUM
$14.5B
This Quarter Return
-12.25%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$7.4B
AUM Growth
-$1.24B
(-14%)
Cap. Flow
-$76.4M
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
1,169
New
145
Increased
375
Reduced
443
Closed
119
Top Buys
| 1 |
Intel
INTC
|
+$42.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$37.3M |
| 3 |
RTN
Raytheon Company
RTN
|
+$34.1M |
| 4 |
F5
FFIV
|
+$28.5M |
| 5 |
WP
Worldpay, Inc.
WP
|
+$28M |
Top Sells
| 1 |
Texas Instruments
TXN
|
+$46.5M |
| 2 |
Fortive
FTV
|
+$23.5M |
| 3 |
Amazon
AMZN
|
+$17.1M |
| 4 |
CDW
CDW
|
+$16.2M |
| 5 |
Verizon
VZ
|
+$15.6M |
Sector Composition
| 1 | Technology | 16.54% |
| 2 | Financials | 13.91% |
| 3 | Healthcare | 13.38% |
| 4 | Real Estate | 11.79% |
| 5 | Consumer Discretionary | 8.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Credit Acceptance
CACC
$5.8B
| $1.34M | 0.02% |
3,500
-700
| -17% | -$267K |
|
527
EPAM Systems
EPAM
$8.53B
| $1.33M | 0.02% |
11,500
+300
| +3% | +$34.8K |
|
|
RPT
528
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $1.33M | 0.02% |
111,200
-12,500
| -10% | -$149K |
|
529
Fulton Financial
FULT
$3.51B
| $1.33M | 0.02% |
85,800
+17,500
| +26% | +$271K |
|
530
Surmodics
SRDX
$459M
| $1.33M | 0.02% |
28,100
+10,200
| +57% | +$482K |
|
|
LOGM
531
DELISTED
LogMein, Inc.
LOGM
| $1.32M | 0.02% |
16,200
-300
| -2% | -$24.5K |
|
532
Rogers Corp
ROG
$1.44B
| $1.31M | 0.02% |
13,200
+800
| +6% | +$79.3K |
|
533
Rexford Industrial Realty
REXR
$10.1B
| $1.3M | 0.02% |
44,100
+29,500
| +202% | +$870K |
|
534
LCI Industries
LCII
$2.47B
| $1.3M | 0.02% |
19,400
+1,200
| +7% | +$80.2K |
|
535
First Industrial Realty Trust
FR
$6.77B
| $1.28M | 0.02% |
44,500
-14,600
| -25% | -$421K |
|
536
Brunswick
BC
$4.23B
| $1.28M | 0.02% |
27,600
+3,100
| +13% | +$144K |
|
|
XEC
537
DELISTED
CIMAREX ENERGY CO
XEC
| $1.28M | 0.02% |
20,800
+7,500
| +56% | +$462K |
|
538
Manhattan Associates
MANH
$12.8B
| $1.28M | 0.02% |
30,200
+1,900
| +7% | +$80.5K |
|
539
Maximus
MMS
$4.94B
| $1.28M | 0.02% |
19,600
-6,700
| -25% | -$436K |
|
|
CMD
540
DELISTED
Cantel Medical Corporation
CMD
| $1.27M | 0.02% |
17,100
-1,100
| -6% | -$81.9K |
|
541
Idexx Laboratories
IDXX
$51B
| $1.27M | 0.02% |
6,800
-2,400
| -26% | -$446K |
|
542
LPL Financial
LPLA
$27.4B
| $1.26M | 0.02% |
20,700
| – | – |
|
543
Ionis Pharmaceuticals
IONS
$10.2B
| $1.26M | 0.02% |
23,300
+1,500
| +7% | +$81.1K |
|
544
Fiserv
FI
$71.8B
| $1.26M | 0.02% |
+17,100
| New | +$1.26M |
|
545
TD Synnex
SNX
$12.5B
| $1.25M | 0.02% |
31,000
| – | – |
|
546
MGIC Investment
MTG
$6.54B
| $1.25M | 0.02% |
119,700
+9,700
| +9% | +$101K |
|
|
VIVO
547
DELISTED
Meridian Bioscience Inc
VIVO
| $1.25M | 0.02% |
71,900
-20,400
| -22% | -$354K |
|
548
Penumbra
PEN
$10.6B
| $1.25M | 0.02% |
10,200
-500
| -5% | -$61.1K |
|
549
Dolby
DLB
$6.8B
| $1.24M | 0.02% |
20,000
-12,700
| -39% | -$785K |
|
550
Charles River Laboratories
CRL
$7.54B
| $1.23M | 0.02% |
10,900
+2,600
| +31% | +$294K |
|